Mulham David Mulham's Form 4 filing
Usana Health Sciences Inc (USNA) · filed Apr 28, 2023
- Accession no.
- 0001415889-23-007032
- Filed
- Apr 28, 2023
- Trade date
- Apr 28, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $76.7K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mulham David MulhamCIK 0001697433 | Officer (CHIEF SALES OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 28, 2023 | Common Stock | SSaleDisposed | −1,138 | $67.40F1 | −$76,701.2 | 13,598 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Weighted average price $67.3984. Price range in multiple transactions was $67.395 to $67.40 inclusively.
Referenced by the price of 1 transaction in Table I.